US HB5776 | 2017-2018 | 115th Congress
Status
Sponsorship: Bipartisan Bill
Status: Introduced on May 11 2018 - 25% progression, died in chamber
Action: 2018-06-19 - Reported (Amended) by the Committee on Ways and Means. H. Rept. 115-764, Part I.
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 11 2018 - 25% progression, died in chamber
Action: 2018-06-19 - Reported (Amended) by the Committee on Ways and Means. H. Rept. 115-764, Part I.
Text: Latest bill text (Introduced) [PDF]
Summary
MOST Act Medicare and Opioid Safe Treatment Act This bill establishes several requirements for the Centers for Medicare & Medicaid Services (CMS), and alters requirements under Medicare and Medicare Advantage, related to pain management and opioid use. For example, the bill requires certified opioid treatment program services to be covered under Medicare. Additionally, among other requirements, the CMS must review payments under Medicare for opioid and non-opioid pain management procedures, specifically with respect to ambulatory outpatient surgical procedures and hospital outpatient department services. The CMS must ensure that there are no payment incentives for using opioids instead of non-opioid alternatives and must make revisions accordingly.The bill also requires payment under Medicare to federally qualified health centers and rural health clinics that have health care practitioners who are newly certified to provide medication-assisted treatment (e.g., buprenorphine).
Title
MOST Act Medicare and Opioid Safe Treatment Act
Sponsors
| Rep. Richard Neal [D-MA] | Rep. George Holding [R-NC] | Rep. Matthew Cartwright [D-PA] | Rep. Scott Taylor [R-VA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2018-06-19 | House | Reported (Amended) by the Committee on Ways and Means. H. Rept. 115-764, Part I. |
| 2018-05-31 | House | Referred to the Subcommittee on Health. |
| 2018-05-16 | House | Ordered to be Reported (Amended) by Voice Vote. |
| 2018-05-16 | House | Committee Consideration and Mark-up Session Held. |
| 2018-05-11 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2018-05-11 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2018-05-11 | House | Introduced in House |
Same As/Similar To
HB5722 (Related) 2018-05-25 - Referred to the Subcommittee on Health.
HB5725 (Related) 2018-05-23 - Referred to the Subcommittee on Health.
HB5769 (Related) 2018-05-30 - Referred to the Subcommittee on Health.
HB5778 (Related) 2018-05-31 - Referred to the Subcommittee on Health.
HB5790 (Related) 2018-05-31 - Referred to the Subcommittee on Health.
SB2875 (Related) 2018-05-17 - Read twice and referred to the Committee on Finance.
HB6 (Related) 2018-10-24 - Became Public Law No: 115-271.
SB3008 (Related) 2018-06-06 - Read twice and referred to the Committee on Finance.
HR1099 (Similar To) 2018-09-28 - Motion to reconsider laid on the table Agreed to without objection.
HB5725 (Related) 2018-05-23 - Referred to the Subcommittee on Health.
HB5769 (Related) 2018-05-30 - Referred to the Subcommittee on Health.
HB5778 (Related) 2018-05-31 - Referred to the Subcommittee on Health.
HB5790 (Related) 2018-05-31 - Referred to the Subcommittee on Health.
SB2875 (Related) 2018-05-17 - Read twice and referred to the Committee on Finance.
HB6 (Related) 2018-10-24 - Became Public Law No: 115-271.
SB3008 (Related) 2018-06-06 - Read twice and referred to the Committee on Finance.
HR1099 (Similar To) 2018-09-28 - Motion to reconsider laid on the table Agreed to without objection.
Subjects
Alternative treatments
Congressional oversight
Drug therapy
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Government information and archives
Government studies and investigations
Health
Health care costs and insurance
Health care coverage and access
Health facilities and institutions
Health personnel
Health programs administration and funding
Health technology, devices, supplies
Home and outpatient care
Hospital care
Medical tests and diagnostic methods
Medicare
Mental health
Rural conditions and development
Surgery and anesthesia
Congressional oversight
Drug therapy
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Government information and archives
Government studies and investigations
Health
Health care costs and insurance
Health care coverage and access
Health facilities and institutions
Health personnel
Health programs administration and funding
Health technology, devices, supplies
Home and outpatient care
Hospital care
Medical tests and diagnostic methods
Medicare
Mental health
Rural conditions and development
Surgery and anesthesia
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/115th-congress/house-bill/5776/all-info |
| Text | https://www.congress.gov/115/bills/hr5776/BILLS-115hr5776ih.pdf |
